Post by
MustBuyloW on May 31, 2020 3:16pm
Pros and cons
Pros: - Owns 10 percent of a promissing alternative trestment for covid - Has very low valuation Cons: - Postponing 2019 financials - Not immediatly filling a PP at half the price of the current stock price which held for over a week. (Is the PP still open?) Is there a reason why investors are not wanting to hold this half-priced deal with amazing warrants for 4 months from pp closing? Feel free to add why a investor should buy before seeing 2019 year end
Comment by
Stock20 on May 31, 2020 6:40pm
This is like VXL did. They announced financing long ago and never filled. Finally stock had run to 0.18 cents on covid-19 news and pp done at 0.075 cents and than run up to 0.32 cents. NSP has big news so far and FDA submission news alone might take us over 0.15 cents.
Comment by
Xstorm2 on Jun 02, 2020 5:29pm
A conservative opinion, MBL. I to hate questioning the PP. I lean toward them leveraging market conditions to maximize their position. The tools were presented, use them. But… 5 years of that logic has put us at record lows.